SMO and prostate cancer: To further stimulate HH signaling in vitro, cells were also exposed to SAG; a well-established SMO agonists shown to for instance stimulate neuronal cell proliferation (Lewis and Krieg, 2014) and prostate cancer cell steroidogenesis (Lubik et al., 2017).